136 related articles for article (PubMed ID: 27311884)
21. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
22. Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
Schroeder MA; Rettig MP; Lopez S; Christ S; Fiala M; Eades W; Mir FA; Shao J; McFarland K; Trinkaus K; Shannon W; Deych E; Yu J; Vij R; Stockerl-Goldstein K; Cashen AF; Uy GL; Abboud CN; Westervelt P; DiPersio JF
Blood; 2017 May; 129(19):2680-2692. PubMed ID: 28292947
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics.
Li J; Hamilton E; Vaughn L; Graiser M; Renfroe H; Lechowicz MJ; Langston A; Prichard JM; Anderson D; Gleason C; Lonial S; Flowers CR; Kaufman JL; Waller EK
Transfusion; 2011 Oct; 51(10):2175-82. PubMed ID: 21492180
[TBL] [Abstract][Full Text] [Related]
24. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
[TBL] [Abstract][Full Text] [Related]
25. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
[TBL] [Abstract][Full Text] [Related]
26. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.
Lane TA; Law P; Maruyama M; Young D; Burgess J; Mullen M; Mealiffe M; Terstappen LW; Hardwick A; Moubayed M
Blood; 1995 Jan; 85(1):275-82. PubMed ID: 7528570
[TBL] [Abstract][Full Text] [Related]
27. Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.
Motlló C; Sancho JM; Grífols JR; Juncà J; Morgades M; Ester A; Rodríguez I; Vives S; Batlle M; Guardia R; Ferrà C; Gallardo D; Millá F; Feliu E; Ribera JM
Cytotherapy; 2014 Mar; 16(3):406-11. PubMed ID: 24176544
[TBL] [Abstract][Full Text] [Related]
28. Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group.
Drozd-Sokołowska J; Waszczuk-Gajda A; Topczewska M; Mańko J; Hus I; Szmigielska-Kapłon A; Nowicki M; Grygoruk-Wiśniowska I; Krawczyk-Kuliś M; Romejko-Jarosińska J; Frączak E; Wróbel T; Piątkowska-Jakubas B; Mądry K; Boguradzki P; Król M; Kozioł M; Hus M; Kopińska A; Dmoszyńska A; Basak GW; Dwilewicz-Trojaczek J
J Clin Apher; 2021 Jun; 36(3):443-453. PubMed ID: 33592119
[TBL] [Abstract][Full Text] [Related]
29. Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors.
Teipel R; Schetelig J; Kramer M; Schmidt H; Schmidt AH; Thiede C; Oelschlägel U; Kroschinsky F; Bornhäuser M; Ehninger G; Hölig K
Transfusion; 2015 Dec; 55(12):2855-63. PubMed ID: 26183707
[TBL] [Abstract][Full Text] [Related]
30. CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients.
Varmavuo V; Mäntymaa P; Silvennoinen R; Nousiainen T; Kuittinen T; Jantunen E
Transfusion; 2013 May; 53(5):1024-32. PubMed ID: 22897584
[TBL] [Abstract][Full Text] [Related]
31. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation.
Rambaldi A; Borleri G; Dotti G; Bellavita P; Amaru R; Biondi A; Barbui T
Blood; 1998 Mar; 91(6):2189-96. PubMed ID: 9490708
[TBL] [Abstract][Full Text] [Related]
32. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
33. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
[TBL] [Abstract][Full Text] [Related]
34. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
[TBL] [Abstract][Full Text] [Related]
35. Autologous Stem Cell Mobilization in the Age of Plerixafor.
Cooper DL; Medoff E; Patel N; Baker J; Pratt K; Foss F; Seropian SE; Perreault S; Wu Y
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):411-6. PubMed ID: 27245311
[TBL] [Abstract][Full Text] [Related]
36. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648
[TBL] [Abstract][Full Text] [Related]
37. The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation.
Bogunia-Kubik K; Gieryng A; Dlubek D; Lange A
Bone Marrow Transplant; 2009 Sep; 44(5):273-8. PubMed ID: 19252530
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in beta-thalassemia patients: kinetics of mobilization and composition of apheresis product.
Li K; Wong A; Li CK; Shing MM; Chik KW; Tsang KS; Lai H; Leung TF; Yuen PM
Exp Hematol; 1999 Mar; 27(3):526-32. PubMed ID: 10089916
[TBL] [Abstract][Full Text] [Related]
39. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
[TBL] [Abstract][Full Text] [Related]
40. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
